Russell Investments Group Ltd. Reduces Stock Position in Varex Imaging $VREX

Russell Investments Group Ltd. lowered its stake in Varex Imaging (NASDAQ:VREX) by 60.6% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 185,745 shares of the company’s stock after selling 285,867 shares during the quarter. Russell Investments Group Ltd. owned 0.45% of Varex Imaging worth $2,155,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in VREX. Aquatic Capital Management LLC purchased a new position in shares of Varex Imaging during the 4th quarter worth $25,000. Point72 Hong Kong Ltd purchased a new position in shares of Varex Imaging during the 4th quarter worth $48,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Varex Imaging by 58.0% during the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 11,279 shares of the company’s stock worth $131,000 after acquiring an additional 4,139 shares during the last quarter. ProShare Advisors LLC purchased a new position in shares of Varex Imaging during the 4th quarter worth $159,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of Varex Imaging during the 1st quarter worth $160,000.

Analysts Set New Price Targets

VREX has been the topic of several analyst reports. Wall Street Zen cut shares of Varex Imaging from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 9th. B. Riley reiterated a “buy” rating and set a $16.00 price target (up previously from $12.00) on shares of Varex Imaging in a research note on Friday, August 8th. Two research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $19.50.

Varex Imaging Stock Down 1.9%

Shares of VREX stock opened at $11.40 on Tuesday. The company has a market capitalization of $473.10 million, a price-to-earnings ratio of -3.55 and a beta of 0.68. Varex Imaging has a one year low of $6.76 and a one year high of $16.93. The company’s fifty day moving average price is $8.61 and its 200-day moving average price is $9.47. The company has a debt-to-equity ratio of 0.78, a current ratio of 3.51 and a quick ratio of 1.82.

Varex Imaging (NASDAQ:VREX) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.18 EPS for the quarter, beating the consensus estimate of $0.04 by $0.14. The firm had revenue of $203.00 million for the quarter, compared to the consensus estimate of $190.32 million. Varex Imaging had a negative net margin of 16.13% and a positive return on equity of 5.54%. Varex Imaging has set its Q4 2025 guidance at 0.100-0.300 EPS. Sell-side analysts expect that Varex Imaging will post 0.53 EPS for the current fiscal year.

Varex Imaging Company Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.